0000908662-16-000397.txt : 20160115
0000908662-16-000397.hdr.sgml : 20160115
20160115162310
ACCESSION NUMBER: 0000908662-16-000397
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160114
FILED AS OF DATE: 20160115
DATE AS OF CHANGE: 20160115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
BUSINESS PHONE: 617-250-5769
MAIL ADDRESS:
STREET 1: 55 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803-2756
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christensen Gustav
CENTRAL INDEX KEY: 0001397709
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24537
FILM NUMBER: 161345716
MAIL ADDRESS:
STREET 1: DYAX CORP.
STREET 2: 300 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-01-14
0000907562
DYAX CORP
DYAX
0001397709
Christensen Gustav
C/O DYAX CORP.
55 NETWORK DRIVE
BURLINGTON
MA
01803-2756
1
1
0
0
CEO and President
Common Stock
2016-01-14
4
M
0
523955
1.41
A
1047134
D
Common Stock
2016-01-14
4
M
0
87500
1.48
A
1134634
D
Common Stock
2016-01-14
4
M
0
333333
2.06
A
1467967
D
Common Stock
2016-01-14
4
M
0
93749
2.06
A
1561716
D
Common Stock
2016-01-14
4
M
0
93750
2.06
A
1655466
D
Common Stock
2016-01-14
4
M
0
46874
2.06
A
1702340
D
Common Stock
2016-01-14
4
M
0
57000
2.06
A
1759340
D
Common Stock
2016-01-14
4
M
0
218749
2.06
A
1978089
D
Common Stock
2016-01-14
4
M
0
207033
3.00
A
2185122
D
Common Stock
2016-01-14
4
M
0
137500
10.20
A
2322622
D
Common Stock
2016-01-14
4
M
0
125000
15.23
A
2447622
D
Stock Option (right to buy)
1.91
2016-01-14
4
M
0
523955
0
D
2021-02-10
Common Stock
523955
0
D
Stock Option (right to buy)
1.48
2016-01-14
4
M
0
87500
0
D
2022-02-24
Common Stock
87500
12500
D
Stock Option (right to buy)
2.06
2016-01-14
4
M
0
333333
0
D
2020-02-10
Common Stock
333333
0
D
Stock Option (right to buy)
2.06
2016-01-14
4
M
0
93749
0
D
2018-08-07
Common Stock
93749
0
D
Stock Option (right to buy)
2.06
2016-01-14
4
M
0
93750
0
D
2018-02-13
Common Stock
93750
0
D
Stock Option (right to buy)
2.06
2016-01-14
4
M
0
46874
0
D
2017-07-02
Common Stock
46874
0
D
Stock Option (right to buy)
2.06
2016-01-14
4
M
0
57000
0
D
2017-06-20
Common Stock
57000
0
D
Stock Option (right to buy)
2.06
2016-01-14
4
M
0
218749
0
D
2019-01-02
Common Stock
218749
0
D
Stock Option (right to buy)
3.00
2016-01-14
4
M
0
207033
0
D
2023-02-07
Common Stock
207033
108333
D
Stock Option (right to buy)
10.20
2016-01-14
4
M
0
137500
0
D
2024-02-27
Common Stock
137500
162500
D
Stock Option (right to buy)
15.23
2016-01-14
4
M
0
125000
0
D
2025-02-18
Common Stock
125000
475000
D
The options were fully exercisable as of February 10, 2015.
The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 24, 2012.
The options were fully exercisable as of June 20, 2014.
The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 7, 2013.
The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 27, 2014.
The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 18, 2015.
/s/ Stacie S. Aarestad as attorney-in-fact
2016-01-15